Curve Therapeutics
Simon Kerry is the Chief Executive Officer of Curve Therapeutics Limited since July 2019, while also holding positions as Operating Partner at Advent Life Sciences LLP and Non-Executive Chairman at Argonaut Therapeutics. With a background in medicinal chemistry and microbiology, Simon has been instrumental in the development of innovative medicines, particularly in the field of inflammatory diseases and cancer. His vast experience in business development and co-founding various companies showcases his expertise in the life sciences industry.
This person is not in any teams
Curve Therapeutics
Our mission is to transform the discovery of first-in-class small molecule therapeutics by broadening the landscape of disease targets that can be drugged. Our Microcycle® platform enables direct screening for biologically active hits inside mammalian cells and creates a toolkit for hit-to-lead programmes. We are deploying our innovative platform to build a pipeline of first-in-class small molecules to address high priority, therapeutically relevant cancer targets.